OliX PharmaceuticalsI Net Income vs. Shares Owned By Institutions

226950 Stock   25,200  500.00  2.02%   
Considering the key profitability indicators obtained from OliX PharmaceuticalsI's historical financial statements, OliX PharmaceuticalsInc may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess OliX PharmaceuticalsI's ability to earn profits and add value for shareholders.
For OliX PharmaceuticalsI profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OliX PharmaceuticalsI to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OliX PharmaceuticalsInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OliX PharmaceuticalsI's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OliX PharmaceuticalsInc over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between OliX PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if OliX PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OliX PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

OliX PharmaceuticalsInc Shares Owned By Institutions vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining OliX PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare OliX PharmaceuticalsI value to that of its competitors to determine the firm's financial worth.
OliX PharmaceuticalsInc is number one stock in net income category among its peers. It also is number one stock in shares owned by institutions category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OliX PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OliX PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

OliX Shares Owned By Institutions vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

OliX PharmaceuticalsI

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(30.28 B)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

OliX PharmaceuticalsI

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
6.02 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

OliX Shares Owned By Institutions Comparison

OliX PharmaceuticalsI is currently under evaluation in shares owned by institutions category among its peers.

OliX Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on OliX PharmaceuticalsI. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OliX PharmaceuticalsI position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OliX PharmaceuticalsI's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in OliX PharmaceuticalsI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

Use Investing Themes to Complement your OliX PharmaceuticalsI position

In addition to having OliX PharmaceuticalsI in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Buywrite ETFs Thematic Idea Now

Buywrite ETFs
Buywrite ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Buywrite ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Buywrite ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in OliX Stock

To fully project OliX PharmaceuticalsI's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OliX PharmaceuticalsInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OliX PharmaceuticalsI's income statement, its balance sheet, and the statement of cash flows.
Potential OliX PharmaceuticalsI investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although OliX PharmaceuticalsI investors may work on each financial statement separately, they are all related. The changes in OliX PharmaceuticalsI's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on OliX PharmaceuticalsI's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.